Bausch Health Companies: Stocks Overvalued by Analyst Consensus on TSX (BHC)
Bausch Health Companies Inc is among the group of overvalued stocks on the Toronto Stock Exchange. This means the consensus value for each stock on this list is below its current price.
This report is generated monthly. It provides the close price and target price for these companies along with the number of analysts covering the stock. Also included is the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year. Stocks in this category are generally sold to preserve capital.
There may be a number of reasons why a company would be on this list. Companies with a large analyst following with a difference in price versus target are worth exploring in more detail.
Symbol | Name | Target Year | Close Price | Target Price Mean | Currency | Target Price # Estimates |
---|---|---|---|---|---|---|
BMO | Bank of Montreal | 2025 | 129.3 | 120.4444 | CAD | 9 |
BNS | Bank of Nova Scotia | 2025 | 75.05 | 72.2 | CAD | 10 |
CM | Canadian Imperial Bank of Commerce | 2025 | 89.55 | 82.6667 | CAD | 9 |
TRP | TC Energy Corp | 2025 | 67.82 | 63.25 | CAD | 8 |
L | Loblaw Companies Ltd | 2025 | 185.51 | 184 | CAD | 7 |
GWO | Great-West Lifeco Inc | 2025 | 49.09 | 48.8571 | CAD | 7 |
NA | National Bank of Canada | 2025 | 133.91 | 129 | CAD | 9 |
DOL | Dollarama Inc | 2025 | 151 | 143.8889 | CAD | 9 |
POW | Power Corporation of Canada | 2025 | 46.57 | 45.1667 | CAD | 6 |
CTC | Canadian Tire Corp Ltd | 2025 | 228.01 | 164.375 | CAD | 8 |
CPX | Capital Power Corp | 2025 | 57.05 | 54.2 | CAD | 10 |
CWB | Canadian Western Bank | 2025 | 58 | 51.9 | CAD | 7 |
BHC | Bausch Health Companies Inc | 2025 | 13.01 | 11.6423 | CAD | 2 |
EQB | EQB Inc | 2025 | 107.5 | 106.875 | CAD | 8 |
CIX | CI Financial Corp | 2025 | 23.74 | 22.4 | CAD | 5 |
TVK | TerraVest Industries Inc | 2025 | 113.11 | 101.6667 | CAD | 3 |
LB | Laurentian Bank of Canada | 2025 | 27.1 | 26.5 | CAD | 8 |
FSZ | Fiera Capital Corp | 2025 | 9.72 | 8.9167 | CAD | 6 |
ECN | ECN Capital Corp | 2025 | 2.93 | 2.4333 | CAD | 6 |
AX-UN | Artis Real Estate Investment Trust | 2025 | 7.81 | 7 | CAD | 1 |
VBNK | VersaBank | 2025 | 22.45 | 20 | CAD | 1 |
TNZ | Tenaz Energy Corp | 2025 | 13.06 | 10.1875 | CAD | 4 |
FCD-UN | Firm Capital Property Trust | 2025 | 5.95 | 5.25 | CAD | 1 |
TNT-UN | True North Commercial REIT | 2025 | 12.45 | 11.3333 | CAD | 3 |
Y | Yellow Pages Ltd | 2025 | 10.4 | 10 | CAD | 1 |
All data provided as of November 08, 2024.
More about Bausch Health Companies Inc
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Bausch Health Companies Inc is listed under BHC on the Toronto Stock Exchange.
Artificial intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.